Melnyk Anita H, McCloskey Nicholas, Hinz Aaron J, Dettman Jeremy, Kassen Rees
Department of Biology and Centre for Advanced Research in Environmental Genomics, University of Ottawa, Ottawa, Ontario, Canada.
Ottawa Research and Development Center, Agriculture and Agri-Food Canada, Ottawa, Ontario, Canada.
mSphere. 2017 Jul 19;2(4). doi: 10.1128/mSphere.00158-17. eCollection 2017 Jul-Aug.
Antibiotic resistance evolves rapidly in response to drug selection, but it can also persist at appreciable levels even after the removal of the antibiotic. This suggests that many resistant strains can both be resistant and have high fitness in the absence of antibiotics. To explore the conditions under which high-fitness, resistant strains evolve and the genetic changes responsible, we used a combination of experimental evolution and whole-genome sequencing to track the acquisition of ciprofloxacin resistance in the opportunistic pathogen under conditions of constant and fluctuating antibiotic delivery patterns. We found that high-fitness, resistant strains evolved readily under fluctuating but not constant antibiotic conditions and that their evolution was underlain by a trade-off between resistance and fitness. Whole-genome sequencing of evolved isolates revealed that resistance was gained through mutations in known resistance genes and that second-site mutations generally compensated for costs associated with resistance in the fluctuating treatment, leading to the evolution of cost-free resistance. Our results suggest that current therapies involving intermittent administration of antibiotics are contributing to the maintenance of antibiotic resistance at high levels in clinical settings. Antibiotic resistance is a global problem that greatly impacts human health. How resistance persists, even in the absence of antibiotic treatment, is thus a public health problem of utmost importance. In this study, we explored the antibiotic treatment conditions under which cost-free resistance arises, using experimental evolution of the bacterium and the quinolone antibiotic ciprofloxacin. We found that intermittent antibiotic treatment led to the evolution of cost-free resistance and demonstrate that compensatory evolution is the mechanism responsible for cost-free resistance. Our results suggest that discontinuous administration of antibiotic may be contributing to the high levels of antibiotic resistance currently found worldwide.
抗生素耐药性会因药物选择而迅速演变,但即便在去除抗生素后,它也能在相当程度上持续存在。这表明许多耐药菌株在没有抗生素的情况下既能保持耐药性又具有高适应性。为了探究高适应性耐药菌株在何种条件下进化以及相关的基因变化,我们结合了实验进化和全基因组测序,以追踪机会致病菌在持续和波动的抗生素给药模式条件下对环丙沙星耐药性的获得情况。我们发现,高适应性耐药菌株在波动而非持续的抗生素条件下很容易进化,并且它们的进化是以耐药性和适应性之间的权衡为基础的。对进化后的分离株进行全基因组测序表明,耐药性是通过已知耐药基因的突变获得的,并且第二位点突变通常补偿了波动治疗中与耐药性相关的代价,从而导致无代价耐药性的进化。我们的结果表明,目前涉及间歇性使用抗生素的疗法正在导致临床环境中抗生素耐药性在高水平维持。抗生素耐药性是一个严重影响人类健康的全球性问题。因此,耐药性如何在即使没有抗生素治疗的情况下持续存在,是一个极其重要的公共卫生问题。在本研究中,我们利用细菌和喹诺酮类抗生素环丙沙星的实验进化,探究了产生无代价耐药性的抗生素治疗条件。我们发现间歇性抗生素治疗导致了无代价耐药性的进化,并证明补偿性进化是无代价耐药性的机制。我们的结果表明,抗生素的间断给药可能是目前全球范围内抗生素耐药性水平高的原因之一。